BioCryst Pharma (BCRX) PT Raised to $14 at RBC Capital
RBC Capital analyst Brian Abraham ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
